These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 5761621)

  • 21. Detection of heterozygotes for phenylketonuria. Total body phenylalanine clearance and concentrations of phenylalanine and tyrosine in the plasms of fasting subjects compared.
    Jagenburg R; Regårdh CG; Rödjer S
    Clin Chem; 1977 Sep; 23(9):1654-60. PubMed ID: 890909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenylalanine tolerance tests. In families with phenylketonuria and hyperphenylalaninemia.
    Cunningham GC; Day RW; Berman JL; Hsia DY
    Am J Dis Child; 1969 Jun; 117(6):626-35. PubMed ID: 5771502
    [No Abstract]   [Full Text] [Related]  

  • 23. 50 years ago in the Journal of Pediatrics: identification of heterozygotes with phenylketonuria on basis of blood tyrosine responses.
    Ross LF
    J Pediatr; 2012 Sep; 161(3):487. PubMed ID: 22916975
    [No Abstract]   [Full Text] [Related]  

  • 24. Phenylalanine loading and aromatic acid excretion in normal subjects and heterozygotes for phenylketonuria.
    Blau K; Summer GK; Newsome HC; Edwards CH
    Clin Chim Acta; 1973 May; 45(3):197-205. PubMed ID: 4708049
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of oral contraceptives and obesity on carrier tests for phenylketonuria.
    Brown ES; Waisman HA; Swanson MA; Colwell RE; Banks ME; Gerritsen T
    Clin Chim Acta; 1973 Mar; 44(2):183-92. PubMed ID: 4699626
    [No Abstract]   [Full Text] [Related]  

  • 26. Detection of phenylketonuric heterozygotes.
    Jackson SH; Hanley WB; Gero T; Gosse GD
    Clin Chem; 1971 Jun; 17(6):538-43. PubMed ID: 5103385
    [No Abstract]   [Full Text] [Related]  

  • 27. Detection of phenylketonuria carriers.
    Kelly S; Rose F
    Public Health Rep (1896); 1969 Feb; 84(2):144-8. PubMed ID: 4980161
    [No Abstract]   [Full Text] [Related]  

  • 28. Contribution to the problems of determining heterozygotes in phenylketonuria by the biochemical and electroencephalographic method.
    Cechák P; Rákosníková M
    Acta Univ Carol Med Monogr; 1977; (79 Pt 3):57-64. PubMed ID: 615484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenylalanine metabolism and intellectual functioning among carriers of phenylketonuria and hyperphenylalaninaemia.
    Ford RC; Berman JL
    Lancet; 1977 Apr; 1(8015):767-71. PubMed ID: 66568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma phenylalanine and tyrosine levels during the day in normal female controls and female obligate phenylketonuria heterozygotes.
    De Groot CJ; Hommes FA
    Enzyme; 1982; 28(4):404-7. PubMed ID: 7151779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The factor analytic, logarithmic and optimum solutions in separating heterozygous carriers and normal control subjects in phenylketonuria.
    Kääriäinen R
    Hereditas; 1973; 75(2):241-9. PubMed ID: 4782045
    [No Abstract]   [Full Text] [Related]  

  • 32. Phenylketonuria heterozygote detection in families with affected children.
    Paul TD; Brandt IK; Elsas LJ; Jackson CE; Mamunes P; Nance CS; Nance WE
    Am J Hum Genet; 1978 May; 30(3):293-301. PubMed ID: 677126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discriminant analysis for detection of phenylketonuric heterozygotes.
    Christian BG
    Soc Biol; 1971 Mar; 18(1):64-72. PubMed ID: 5580588
    [No Abstract]   [Full Text] [Related]  

  • 34. Phenylketonuria, a family study. Borderline intelligence in two siblings with mentally retarded children.
    Colombo JP; Vassella F; Humbel R; Rossi E
    Helv Paediatr Acta; 1967 Jul; 22(3):243-51. PubMed ID: 5592735
    [No Abstract]   [Full Text] [Related]  

  • 35. Plasma phenylalanine, tyrosine, and tryptophan in schizophrenia.
    Potkin SG; Cannon-Spoor HE; DeLisi LE; Neckers LM; Wyatt RJ
    Arch Gen Psychiatry; 1983 Jul; 40(7):749-52. PubMed ID: 6860076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Fetal brain damage in maternal heterozygous phenylketonuria].
    Kutter D; Humbel R; Metz H
    Med Klin; 1970 Apr; 65(14):653-6. PubMed ID: 5507797
    [No Abstract]   [Full Text] [Related]  

  • 37. The role of heterozygosity of women with respect to the phenylketonuria gene in the origin of spontaneous abortions and disturbances of intrauterine fetal development.
    Blyumina MG
    Sov Genet; 1974 May; 8(3):385-90. PubMed ID: 4846205
    [No Abstract]   [Full Text] [Related]  

  • 38. Carrier screening for phenylketonuria: comparison of two discriminant analysis procedures.
    Freehauf CL; Lezotte D; Goodman SI; McCabe ER
    Am J Hum Genet; 1984 Nov; 36(6):1180-9. PubMed ID: 6517048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperphenylalaninemia in a premature infant with heterozygosity for phenylketonuria.
    Hennermann JB; Loui A; Weber A; Mönch E
    J Perinat Med; 2004; 32(4):383-5. PubMed ID: 15346830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discrimination of heterozygotes for phenylketonuria, persistent hyperphenylalaninemia and controls by phenylalanine loading.
    Blitzer MG; Bailey-Wilson JE; Shapira E
    Clin Chim Acta; 1986 Dec; 161(3):347-52. PubMed ID: 3802540
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.